Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...

As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia. Shingles, caused by the ...

The agency’s top vaccine regulator proposed broad changes, claiming that a new review linked 10 children’s deaths to the Covid vaccine. But public health experts questioned the findings, wanting to ...

For children — and many adults — the fear of injections remains a major barrier to vaccination. But research led by Elodie Segura, PhD, from the Immunity and Cancer Laboratory at the Institut Curie in ...

Acting CDC Director Jim O’Neill on Monday called on vaccine manufacturers to develop separate shots for measles, mumps and rubella instead of the current vaccine, which combines the three. O’Neill ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

CNBC’s Angelica Peebles and Merck chairman and CEO Rob Davis join 'Squawk Box' to discuss the FDA's approval of the injectable version of Keytruda, pricing for the new injection, navigating the new ...

Friday, a key federal advisory panel capped two days of confusing and often tense discussion on several new vaccine recommendations. Public health experts and doctors say the panel's chaotic voting ...